By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Lycopodium clavatum

Sound forms: Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs
ⓘ Learn more about digital audio preparations

Performance statistics based

X
 
  • 4
    Pelvis: E 43%, I 11%, 39 cases. 422 meds
    • 122
      Diseases: E 42%, I 10%, 451 case. 1806 meds
      • 8
        Back: E 48%, I 8%, 118 cases. 819 meds
        • 16
          Digestive system: E 40%, I 8%, 508 cases. 1228 meds
          • 10
            Respiratory system: E 47%, I 7%, 412 cases. 938 meds
            • 4
              Down neck: E 29%, I 6%, 84 cases. 682 meds
              • 6
                Chest: E 54%, I 6%, 108 cases. 981 meds
                • 11
                  Abdomen: E 47%, I 6%, 204 cases. 1011 meds
                  • 17
                    Limbs: E 35%, I 6%, 382 cases. 892 meds
                    • 23
                      Skin: E 31%, I 5%, 467 cases. 1213 meds
                      • 6
                        Bone system: E 39%, I 4%, 211 cases. 238 meds
                        • 16
                          Head: E 36%, I 4%, 524 cases. 1190 meds
                          • 7
                            Nervous system: E 39%, I 4%, 116 cases. 484 meds
                            • 5
                              Anamnesis: E 30%, I 3%, 150 cases. 645 meds
                              • 40
                                Common symptoms: E 24%, I 3%, 21 case. 698 meds
                                • 5
                                  Cardiovascular system: E 35%, I 2%, 229 cases. 1060 meds
                                  • 16
                                    Psyche: E 25%, I 2%, 562 cases. 1247 meds
                                    • 14
                                      The muscular system: E 37%, I -2%, 98 cases. 212 meds
                                      • 6
                                        Genitourinary system: E 28%, I -3%, 220 cases. 367 meds

                                        Last updated date: 29.08.2024

                                        Performance statistics based «Lycopodium clavatum» in percentages for various lesions, grouped by meaning in the form of a repertory. Together with individual modalities that affect the outcome of therapy.
                                        Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) is negative, because the patient will get worse over time.
                                        Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
                                        Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
                                        Available only when using PRO account
                                        Content moderator: Vasin A. S.


                                        1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
                                        2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
                                        3. Nothing in the information provided should be interpreted as a call to use these drugs.
                                        4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.